Tuesday, May 26, 2026 | 2:00–3:00 PM CDT | Virtual
Contact Hours: 1.0
Target Audience: Pharmacists
UAN: 0217-0000-26-056-L01-P
Activity Type: Knowledge
Fees & Registration
Critical Care and/or Central Nervous System PRN Members: $0.00
ACCP Members: $10.00
Non-ACCP Members: $20.00
|
Register Now |
Description:
With expanding use of antiplatelet therapies in neurocritical care, pharmacists are increasingly challenged to navigate complex transitions between parenteral and oral agents in this high-risk population. Despite growing reliance on P2Y12 and aspirin platelet function assays, their optimal use, clinical significance, and interpretation remain debated in the literature. Decisions regarding when to order assays, how to interpret results, and how to adjust therapy are still evolving. This program will emphasize interpreting platelet function assays, managing therapy transitions, and developing individualized antiplatelet strategies in complex neurovascular patients.
Learning Objectives:
- Describe commonly utilized testing for the monitoring of antiplatelet therapies.
- Summarize the transition from parenteral and oral antiplatelet therapy, including the significance of loading doses and the consideration of dual or triple antiplatelet therapy.
- Outline a treatment plan for patients in the neurocritical care setting who may benefit from therapeutic drug monitoring of antiplatelet therapy.
Speakers:
Roxana Dumitru, Pharm.D., BCCCP, BCPS
Senior Clinical Pharmacy Manager - Neurosciences ICU
New York Presbyterian - Columbia University Irving Medical Center/
New York, New York
Ryley Uber, Pharm.D.
Pharmacogenomics Program Director and Assistant Professor/
Geisinger Health System
Danville, PA
Technical Requirements
This webinar will be conducted on Zoom. View Zoom System Requirements.
Commercial Support
The American College of Clinical Pharmacy does not solicit or accept external commercial/financial support for its continuing pharmacy education activities. No commercial/financial support has been solicited or accepted for this activity.
Continuing Pharmacy Education Credit
The American College of Clinical Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
To obtain your CPE credit after the event, please visit www.accp.com, sign in, and complete the attestation statement related to this activity. You must claim your CPE by July 26, 2026. Statements of credit will be available via CPE Monitor within 2–3 business days of claiming credit. ACCP cannot issue CPE credit to any participant who does not have a date of birth and NABP e-Profile ID number on file with ACCP. Credit will not be awarded after July 26, 2026.